LabCompass

Michael Kays

Medicine · Purdue University West Lafayette

Established · publishing since 1990

Publications

54

Citations

1,281

Est. group size

Recurring co-author estimate

Active years

36

Publishing since 1990

Research summary
AI-generated

Michael Kays studies how antibiotics behave in the body (pharmacokinetics) and how effectively they fight infection (pharmacodynamics), with a particular focus on how body weight, obesity, and critical illness affect proper antibiotic dosing. Much of the work models drug levels in hospitalized patients to help determine safer, more effective dosing strategies for antibiotics such as cefazolin, cefepime, cephalexin, meropenem, and doripenem.

Antibiotic dosing and pharmacokineticsEffects of obesity and body weight on drug behaviorAntibiotic pharmacodynamics (relating drug levels to effectiveness)Critically ill and hospitalized patient populationsAntimicrobial resistance and infectious disease management

Publication output has been low and irregular over the last decade, with several years of no recorded output followed by small upticks (about 0.8 papers per year on average in the last 5 years).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 0.8/year recently
17182019: 2 publications219202021: 1 publication21222023: 2 publications2232024: 1 publication242025: 1 publication2526
Publishes in
  • Open Forum Infectious Diseases×5
  • The Journal of Clinical Pharmacology×2
  • International Journal of Antimicrobial Agents×1
  • Infection Prevention in Practice×1
  • Annals of Pharmacotherapy×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile